Literature DB >> 22753018

Dose dependent expression of HDAC4 causes variable expressivity in a novel inherited case of brachydactyly mental retardation syndrome.

Benjamin Morris1, Cécile Etoubleau, Sylvie Bourthoumieu, Sandrine Reynaud-Perrine, Cécile Laroche, Aziza Lebbar, Catherine Yardin, Sarah H Elsea.   

Abstract

Histone deacetylase 4 (HDAC4) serves important roles in multiple human systems, including neurological, cardiac, and skeletal functions. Mutation or deletion of HDAC4 causes brachydactyly mental retardation syndrome (BDMR), a disorder that includes intellectual disability, behavioral abnormalities, autism spectrum disorder, and craniofacial and skeletal anomalies, including brachydactyly type E. We present a case of familial BDMR, including a parent with mild symptoms of the disorder and a child exhibiting a more severe phenotype. Cytogenetic testing showed a cryptic balanced translocation in the mother that resulted in a 2q37.1 monosomy and a 10q26.1 trisomy in the son. Gene expression analyses demonstrated 67% HDAC4 expression in the mother and 23% HDAC4 expression in the son relative to normal controls, lending evidence to the hypothesis that HDAC4 modulates severity of this disorder in a dosage-dependent manner.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22753018     DOI: 10.1002/ajmg.a.35463

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  15 in total

Review 1.  Genetic syndromes caused by mutations in epigenetic genes.

Authors:  María Berdasco; Manel Esteller
Journal:  Hum Genet       Date:  2013-01-31       Impact factor: 4.132

Review 2.  Mendelian disorders of the epigenetic machinery: tipping the balance of chromatin states.

Authors:  Jill A Fahrner; Hans T Bjornsson
Journal:  Annu Rev Genomics Hum Genet       Date:  2014       Impact factor: 8.929

3.  Long-Term Memory in Drosophila Is Influenced by Histone Deacetylase HDAC4 Interacting with SUMO-Conjugating Enzyme Ubc9.

Authors:  Silvia Schwartz; Mauro Truglio; Maxwell J Scott; Helen L Fitzsimons
Journal:  Genetics       Date:  2016-05-06       Impact factor: 4.562

4.  Reorganization of inter-chromosomal interactions in the 2q37-deletion syndrome.

Authors:  Philipp G Maass; Anja Weise; Katharina Rittscher; Julia Lichtenwald; A Rasim Barutcu; Thomas Liehr; Atakan Aydin; Yvette Wefeld-Neuenfeld; Laura Pölsler; Sigrid Tinschert; John L Rinn; Friedrich C Luft; Sylvia Bähring
Journal:  EMBO J       Date:  2018-06-19       Impact factor: 11.598

5.  Exome Sequencing Reveals De Novo Variants in Congenital Scoliosis.

Authors:  Kohei Murakami; Shingo Kikugawa; Shoji Seki; Hidetomi Terai; Takako Suzuki; Masaki Nakano; Jun Takahashi; Yukio Nakamura
Journal:  J Pediatr Genet       Date:  2021-04-14

Review 6.  From neural development to cognition: unexpected roles for chromatin.

Authors:  Jehnna L Ronan; Wei Wu; Gerald R Crabtree
Journal:  Nat Rev Genet       Date:  2013-04-09       Impact factor: 53.242

7.  Phenotypic variant of Brachydactyly-mental retardation syndrome in a family with an inherited interstitial 2q37.3 microdeletion including HDAC4.

Authors:  Pablo Villavicencio-Lorini; Eva Klopocki; Marc Trimborn; Randi Koll; Stefan Mundlos; Denise Horn
Journal:  Eur J Hum Genet       Date:  2012-11-28       Impact factor: 4.246

Review 8.  Brachydactyly E: isolated or as a feature of a syndrome.

Authors:  Arrate Pereda; Intza Garin; Maria Garcia-Barcina; Blanca Gener; Elena Beristain; Ane Miren Ibañez; Guiomar Perez de Nanclares
Journal:  Orphanet J Rare Dis       Date:  2013-09-12       Impact factor: 4.123

9.  Testicular sex cord-stromal tumor in a boy with 2q37 deletion syndrome.

Authors:  Yasunari Sakai; Ryota Souzaki; Hidetaka Yamamoto; Yuki Matsushita; Hazumu Nagata; Yoshito Ishizaki; Hiroyuki Torisu; Yoshinao Oda; Tomoaki Taguchi; Chad A Shaw; Toshiro Hara
Journal:  BMC Med Genomics       Date:  2014-04-22       Impact factor: 3.063

10.  A novel 2q37 microdeletion containing human neural progenitors genes including STK25 results in severe developmental delay, epilepsy, and microcephaly.

Authors:  Jaime Imitola; Divya S Khurana; Nadiya M Teplyuk; Mark Zucker; Reena Jethva; Agustin Legido; Ana M Krichevsky; Michael Frangieh; Christopher A Walsh; Karen S Carvalho
Journal:  Am J Med Genet A       Date:  2015-08-04       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.